Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Cyteir Therapeutics, Inc.
Eli Lilly and Company
City of Hope Medical Center
University of Chicago
Masonic Cancer Center, University of Minnesota
Altor BioScience
Dartmouth-Hitchcock Medical Center